Michael J. Dattoli, MD, is a board-certiﬁed radiation oncologist with decades of brachytherapy experience, having performed thousands of prostate implant procedures. Dr. Dattoli attended the University of California at Berkeley and was the Valedictorian of his class at Vassar College. He earned his medical degree at Mount Sinai School of Medicine, Radiation Oncology at New […]
By Reggie Kumar | August 05, 2016 Researchers at the UCLA Jonsson Comprehensive Cancer Center say findings in new study will help physicians and patients make informed decisions. For the full article, please visit UCLA Newsroom.
Testosterone: Friend or Foe? MICHAEL DATTOLI, MD & GINYA CARNAHAN, APR, CRPC Perhaps one of the most controversial subjects in the prostate cancer world is the role of testosterone – its influence on the development of prostate cancer, its impact on current tumor growth, and more recently its possible ability to slow the growth of […]
(June 10, 2014 – Sarasota, FL) This week Dattoli Cancer Center & Brachytherapy Research Institute became the first independent physician practice in the U.S. to offer men with advanced metastatic prostate cancer an injectable isotope of radium, marketed by Bayer as Xofigo® (zoh-fee-go). This new pharmaceutical was recently FDA approved for use in men with […]
Saturday, May 1, 2004 Incurable PCa? Consider Brachytherapy Over the past decade, prostate brachytherapy has gained increasing popularity for the treatment of prostate cancer, especially in view of the favorable side-effect profile when compared to alternative therapies. The number of patients treated with this modality is now on par with both radical prostatectomy and full-course […]